SEARCH · Search NASA
Results for “Biomedical”
Search indexed NASA NTRS and DOE OSTI research on propulsion, heat transfer, battery materials and energy systems. Follow report and document links to the original sources.
Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.
Bioinspired Nanoscale Materials for Biomedical and Energy Applications
The demand of green, affordable and environmentally sustainable materials has encouraged scientists in different fields to draw inspiration from nature in developing materials with unique properties such as miniaturization, hierarchical organization, and adaptability. Together with the exceptional properties of nanomaterials, over the past century, the field of bioinspired nanomaterials has taken huge leaps. While on one hand, the sophistication of hierarchical structures endow biological systems with multifunctionality, the synthetic control on the creation of nanomaterials enables the design of materials with specific functionalities. The aim of this review is to provide a comprehensive, up-to-date overview of the field of bioinspired nanomaterials, which we have broadly categorized into biotemplates and biomimics. We will discuss the application of bioinspired nanomaterials as biotemplates in catalysis, nanomedicine, immunoassays and in energy, drawing attention to novel materials such as protein cages. Further, the applications of bioinspired materials in tissue engineering and biomineralization will also be discussed.
A method of measuring gold nanoparticle concentrations by x-ray fluorescence for biomedical applications
Purpose: This paper reports a technique that enables the quantitative determination of the concentration of gold nanoparticles (GNPs) through the accurate detection of their fluorescence radiation in the diagnostic x-ray spectrum. Methods: Experimentally, x-ray fluorescence spectra of 1.9 and 15 nm GNP solutions are measured using an x-ray spectrometer, individually and within chicken breast tissue samples. An optimal combination of excitation and emission filters is determined to segregate the fluorescence spectra at 66.99 and 68.80 keV from the background scattering. A roadmap method is developed that subtracts the scattered radiation (acquired before the insertion of GNP solutions) from the signal radiation acquired after the GNP solutions are inserted. Results: The methods effectively minimize the background scattering in the spectrum measurements, showing linear relationships between GNP solutions from 0.1% to 10% weight concentration and from 0.1% to 1.0% weight concentration inside a chicken breast tissue sample. Conclusions: The investigation demonstrated the potential of imaging gold nanoparticles quantitatively in vivo for in-tissue studies, but future studies will be needed to investigate the ability to apply this method to clinical applications.
Properties of MgFe{sub 2}O{sub 4} Nanoparticles Synthesized by Ultrasonic Aerosol Pyrolysis for Biomedical Applications
We present the data of studies on the structure, phase states, and magnetic properties of magnetic nanoparticles (MNPs) of magnesium ferrite spinel (MgFe{sub 2}O{sub 4}), synthesized by ultrasonic aerosols pyrolysis. Primary single-phase MNPs with an average size of 9.6, 11.5, and 14.0 nm, synthesized from precursors at concentrations of 0.06, 0.12, and 0.24 M, respectively, agglomerate into tightly aggregated spherical particles (secondary particles) with sizes of 206, 300, and 340 nm, respectively. Primary particles inside the spheres do not interact with each other and are in a superparamagnetic state. There is a layer on the surface of the particles, the magnetic structure of which differs from the structure of the inner part of the MNP; this is explained by the formation of a canted spin structure or a spin glass state in the surface layer of the MNPs. MgFe{sub 2}O{sub 4} nanospheres obtained from a precursor at a concentration of 0.06 M are most promising as valid sources of heat in magnetic hyperthermia therapy.
Nanoporous aluminum oxide membranes coated with atomic layer deposition-grown titanium dioxide for biomedical applications: An in vitro evaluation
The surface topographies of nanoporous anodic aluminum oxide (AAO) and titanium dioxide (TiO 2 ) membranes have been shown to modulate cell response in orthopedic and skin wound repair applications. In this study, we: (1) demonstrate an improved atomic layer deposition (ALD) method for coating the porous structures of 20, 100, and 200 nm pore diameter AAO with nanometer-thick layers of TiO 2 and (2) evaluate the effects of uncoated AAO and TiO 2 -coated AAO on cellular responses. The TiO 2 coatings were deposited on the AAO membranes without compromising the openings of the nanoscale pores. The 20 nm TiO 2 -coated membranes showed the highest amount of initial protein adsorption via the micro bicinchoninic acid (micro-BOA) assay; all of the TiO 2 -coated membranes showed slightly higher protein adsorption than the uncoated control materials. Cell viability, proliferation, and inflammatory responses on the TiO 2 -coated AAO membranes showed no adverse outcomes. For all of the tested surfaces, normal increases in proliferation (DNA content) of L929 fibroblasts were observed over from 4 hours to 72 hours. No increases in TNF-alpha production were seen in RAW 264.7 macrophages grown on TiO 2 -coated AAO membranes compared to uncoated AAO membranes and tissue culture polystyrene (TOPS) surfaces. Both uncoated AAO membranes and TiO 2 -coated AAO membranes showed no significant effects on cell growth and inflammatory responses. In conclusion, the results suggest that TiO 2 -coated AAO may serve as a reasonable prototype material for the development of nanostructured wound repair devices and orthopedic implants.
Biotechnology development for biomedical applications.
Sandia's scientific and engineering expertise in the fields of computational biology, high-performance prosthetic limbs, biodetection, and bioinformatics has been applied to specific problems at the forefront of cancer research. Molecular modeling was employed to design stable mutations of the enzyme L-asparaginase with improved selectivity for asparagine over other amino acids with the potential for improved cancer chemotherapy. New electrospun polymer composites with improved electrical conductivity and mechanical compliance have been demonstrated with the promise of direct interfacing between the peripheral nervous system and the control electronics of advanced prosthetics. The capture of rare circulating tumor cells has been demonstrated on a microfluidic chip produced with a versatile fabrication processes capable of integration with existing lab-on-a-chip and biosensor technology. And software tools have been developed to increase the calculation speed of clustered heat maps for the display of relationships in large arrays of protein data. All these projects were carried out in collaboration with researchers at the University of Texas M. D. Anderson Cancer Center in Houston, TX.
Pioneer Valley Life Sciences Institute Translational Biomedical Research
The work detailed in this proposal consists of two major projects aimed at developing prognostic indicators and therapeutic interventions for breast cancer. The overall progress of each project is provided along with the manuscripts resulting from the work to date. All major goals of the projects were completed. In addition to the progress reports provided below, detailed discussion of the results can be found in the 5 manuscripts resulting from this award (citations provided below). Overall, the projects have identified 2 new protein biomarkers (Acheron and YKL-40) that participate directly in progression of breast cancer. Therefore, drugs interrupting these pathways should provide effective new therapies for a subset of breast cancers. This provides a further step toward paired diagnostics and therapeutics. In this manner, breast cancer therapies can be tailored to provide the most appropriate drugs for each individual yielding improved survival. Delivery of drugs is another major hurdle for successful treatment of breast cancer. Therefore, the research has also developed new polymeric delivery vehicles. The scaffolds not only improve efficacy of existing drugs, but also provide a flexible platform that can be adapted to deliver a wide array of small molecule and protein therapeutics.
Annual Progress Report for the Resource for the Development of Biomedical Accelerator Mass Spectrometry (AMS)
Abstract not provided.
Collaborative Initiative in Biomedical Imaging to Study Complex Diseases
The work reported addressed these topics: Fluorescence imaging; Optical coherence tomography; X-ray interferometer/phase imaging system; Quantitative imaging from scattered fields, Terahertz imaging and spectroscopy; and Multiphoton and Raman microscopy.
Biomedical Applications of Microfluidic Technology
This presentation describes the various applications for microfluidic technology.
Report of the Third Biomedical Confidence Building Exercise
Abstract not provided
Computational simulations and methods for biomedical applications
Explore the source record for details and available documents.
Periodically patterned structures for nanoplasmonic and biomedical applications
Explore the source record for details and available documents.
Development of Low Temperature Microplasma Lamps for Biomedical Applications
For several, widespread dermatologic disorders such as psoriasis and Bowman’s disease, no cure currently exists but the irradiation of the affected tissue at specific wavelengths in the ultraviolet (UV) is the only known therapeutic treatment that drives the disorder into remission. Furthermore, currently available treatments based on lasers are expensive and access is severely restricted for the millions of patients (in the U.S. alone) who suffer from these diseases. Recently, however, microcavity plasma technology developed at Eden Park Illumination (EPI) and the University of Illinois has resulted in flat (or curved) lamps that are thin and capable of emitting UV at discrete wavelengths. EPI has, for example, commercialized lamps as large as 4” × 4” (100 cm 2 ) in emitting area that generate more than 10 W of average power at 172 nm. These results are well beyond the performance available in the past from lamps emitting in the deep-ultraviolet, and it appears that this technology can be readily modified to operate at other UV wavelengths.
Data-consistent Approaches to Modeling Population Distributions of Parameters for Biomedical Systems.
Abstract not provided.
SELF-HEALING HIGH-ENTROPY ALLOYS AND CERAMICS FOR BIOMEDICAL APPLICATIONS
Explore the source record for details and available documents.